000			02202 a2200649 4500
005			20250518084637.0
264		0	_c20200506
008			202005s 0 0 fre d
022			_a1769-6917
024	7		_a10.1016/j.bulcan.2019.11.016 _2doi
040			_aNLM _beng _cNLM
100	1		_aCohen, Romain
245	0	0	_a[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]. _h[electronic resource]
260			_bBulletin du cancer _cApr 2020
300			_a438-446 p. _bdigital
500			_aPublication Type: Clinical Trial Protocol; Journal Article
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAntineoplastic Agents, Immunological _xtherapeutic use
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aDNA Mismatch Repair
650	0	4	_aDisease-Free Survival
650	0	4	_aHumans
650	0	4	_aIpilimumab _xtherapeutic use
650	0	4	_aMicrosatellite Instability
650	0	4	_aMulticenter Studies as Topic
650	0	4	_aNeoadjuvant Therapy _xmethods
650	0	4	_aNivolumab _xtherapeutic use
650	0	4	_aPatient Selection
650	0	4	_aPerioperative Care
650	0	4	_aPhenotype
650	0	4	_aStomach Neoplasms _xdrug therapy
650	0	4	_aTreatment Outcome
700	1		_aPudlarz, Thomas
700	1		_aGarcia-Larnicol, Marie-Line
700	1		_aVernerey, Dewi
700	1		_aDray, Xavier
700	1		_aClavel, Léa
700	1		_aJary, Marine
700	1		_aPiessen, Guillaume
700	1		_aZaanan, Aziz
700	1		_aAparicio, Thomas
700	1		_aLouvet, Christophe
700	1		_aTournigand, Christophe
700	1		_aChibaudel, Benoist
700	1		_aTougeron, David
700	1		_aGuimbaud, Rosine
700	1		_aBenouna, Jaafar
700	1		_aAdenis, Antoine
700	1		_aSokol, Harry
700	1		_aBorg, Christophe
700	1		_aDuval, Alex
700	1		_aSvrcek, Magali
700	1		_aAndré, Thierry
773	0		_tBulletin du cancer _gvol. 107 _gno. 4 _gp. 438-446
856	4	0	_uhttps://doi.org/10.1016/j.bulcan.2019.11.016 _zAvailable from publisher's website
999			_c30633930 _d30633930